ABC | Volume 110, Nº4, Abril 2018

Editorial Scanavacca e Bocchi Ablação de fibrilação atrial por cateter em pacientes com insuficiência cardíaca Arq Bras Cardiol. 2018; 110(4):300-302 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 11. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al; CASTLE-AF Investigators. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417-27. 12. Black-Maier E, Ren X, Steinberg BA, Green CL, Barnett AS, Rosa NS, et al. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction. Heart Rhythm. 2017 Dec 6. [Epub ahead of print]. 13. Machino-Ohtsuka T, Seo Y, Ishizu T, Sugano A, Atsumi A, Yamamoto M, et al. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failurewith preserved ejection fraction. J AmColl Cardiol. 2013;62(20):1857-65. 14. Kheirkhahan M, Marrouche NF. It is time for catheter ablation to be considered a first-line treatment option in patients with atrial fibrillation and heart failure. Heart Rhythm. 2018 Feb 8. [Epub ahead of print]. 15. Calvo N, Bisbal F, Guiu E, Ramos P, Nadal M, Tolosana JM, et al. Impact of atrial fibrillation-induced tachycardiomyopathy in patients undergoing pulmonary vein isolation. Int J Cardiol. 2013;168(4):4093-7. 302